tv3326 has been researched along with ciproxifan in 1 studies
| Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (ciproxifan) | Trials (ciproxifan) | Recent Studies (post-2010) (ciproxifan) |
|---|---|---|---|---|---|
| 15 | 0 | 11 | 106 | 0 | 46 |
| Protein | Taxonomy | tv3326 (IC50) | ciproxifan (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 2.0333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Mishra, P; Panda, G | 1 |
1 review(s) available for tv3326 and ciproxifan
| Article | Year |
|---|---|
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents | 2019 |